Reducing postoperative infections with Steriwave
Using real-world evaluations to accelerate the adoption of innovation
We have supported six companies with real-world evaluations to help them assess the effectiveness of their innovations and build their evidence-base for adoption, so that their solutions can be spread more easily across the NHS.
Our real-world evaluation projects help to accelerate the adoption of innovative healthcare technologies by collaborating with innovators and NHS organisations to carry out independent evaluations of new healthcare technologies in a real-world setting. This supports the spread of proven, evidence-based solutions which will improve health outcomes in the NHS.
Real-world evaluations are conducted to ensure that innovations are clinically effective when trialled by patients,
and to understand the costeffectiveness of a solution. Our work helps innovators to build their value proposition and also contributes to the economic growth of the region.
By bridging the gap between innovation and NHS adoption, our real-world evidence programme plays a crucial role in improving healthcare delivery and outcomes in the Yorkshire and Humber region.
Reducing postoperative infections with Steriwave
Postoperative infections are a major problem for hospitals, harming patients and incurring significant care costs to the NHS.
Steriwave is a new alternative to antibiotics. It uses red light to kill germs in the nose before surgery, preventing infections without contributing to antibiotic resistance. Mid Yorkshire Teaching NHS Trust successfully trialled Steriwave for hip and knee surgery patients and has now adopted it as standard care.
We supported an independent economic evaluation of the Steriwave pilot, which was undertaken by York Health Economics Consortium( YHEC), the results showed:
• Potential savings of £ 86,650 per 1,000 hip surgery patients.
• Potential savings of £ 84,430 per 1,000 knee surgery patients.
• Overall potential savings of £ 38,180 per 1,000 patients.
Support for innovators
34 Transforming Lives Through Innovation
Sickness to prevention
Economic growth